• 1. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 2. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 3. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 4. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 5. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389

Introduction to 6-nitro-2,3-dihydro-1H-indole hydrochloride (CAS No. 1187929-53-8)

6-nitro-2,3-dihydro-1H-indole hydrochloride (CAS No. 1187929-53-8) is a versatile compound with significant applications in the fields of chemical biology and medicinal chemistry. This compound, characterized by its unique structural features, has garnered attention for its potential in various research and therapeutic contexts. In this comprehensive introduction, we will delve into the chemical properties, synthesis methods, biological activities, and recent research advancements related to 6-nitro-2,3-dihydro-1H-indole hydrochloride.

Chemical Structure and Properties

6-nitro-2,3-dihydro-1H-indole hydrochloride is a derivative of indole, a fundamental heterocyclic compound with a wide range of biological activities. The presence of the nitro group at the 6-position and the dihydro configuration at the 2,3 positions imparts unique chemical and physical properties to this compound. The molecular formula of 6-nitro-2,3-dihydro-1H-indole hydrochloride is C₉H₉N₂O₂·HCl, with a molecular weight of approximately 207.64 g/mol.

The compound is typically obtained as a white or off-white crystalline solid and is soluble in common organic solvents such as methanol, ethanol, and dimethyl sulfoxide (DMSO). Its solubility in water is limited but can be enhanced by the addition of acids or bases. The presence of the hydrochloride salt form improves its solubility in aqueous solutions, making it suitable for various biological assays and pharmaceutical applications.

Synthesis Methods

The synthesis of 6-nitro-2,3-dihydro-1H-indole hydrochloride has been extensively studied and optimized over the years. One of the most common synthetic routes involves the nitration of 2,3-dihydroindole followed by acidification to form the hydrochloride salt. This method typically involves the use of nitric acid or other nitrating agents under controlled conditions to ensure high yields and purity.

An alternative approach involves the condensation of an appropriate ketone or aldehyde with an amine followed by cyclization and nitration steps. This multi-step process allows for greater control over the substitution pattern and can be tailored to produce various derivatives of 6-nitro-2,3-dihydro-1H-indole hydrochloride.

Biological Activities

6-nitro-2,3-dihydro-1H-indole hydrochloride has been investigated for its diverse biological activities, including anti-inflammatory, antiviral, and anticancer properties. Recent studies have highlighted its potential as a lead compound for drug development in these areas.

In anti-inflammatory research, 6-nitro-2,3-dihydro-1H-indole hydrochloride has shown promising results in inhibiting pro-inflammatory cytokines such as TNF-alpha and IL-6. These findings suggest its potential use in treating inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

In antiviral studies, this compound has demonstrated activity against various viral strains, including herpes simplex virus (HSV) and human immunodeficiency virus (HIV). The mechanism of action involves interference with viral replication processes and modulation of host cell signaling pathways.

In cancer research, 6-nitro-2,3-dihydro-1H-indole hydrochloride has been found to exhibit cytotoxic effects on several cancer cell lines. It appears to induce apoptosis through mitochondrial dysfunction and DNA damage. These properties make it a candidate for further investigation as a potential anticancer agent.

Clinical Applications and Research Advancements

The potential clinical applications of 6-nitro-2,3-dihydro-1H-indole hydrochloride are currently being explored through preclinical studies and early-stage clinical trials. Recent advancements in drug delivery systems have enhanced its bioavailability and efficacy in vivo.

Nanoparticle-based formulations have shown promise in improving the pharmacokinetic profile of this compound. These formulations can protect the drug from degradation in the gastrointestinal tract and facilitate targeted delivery to specific tissues or organs.

In addition to its direct therapeutic effects, 6-nitro-2,3-dihydro-1H-indole hydrochloride has also been studied as a tool compound in chemical biology research. Its ability to modulate specific signaling pathways makes it valuable for investigating cellular processes involved in disease pathogenesis.

Safety Considerations

Safety is a critical aspect when considering the use of any new chemical entity in therapeutic applications. Preclinical toxicity studies have indicated that 6-nitro-2,3-dihydro-1H-indole hydrochloride is generally well-tolerated at therapeutic doses. However, like all compounds with biological activity, it may have potential side effects that need to be carefully monitored during clinical trials.

To ensure safe use in humans, ongoing research is focused on optimizing dosing regimens and identifying any potential interactions with other medications or dietary supplements. Additionally, efforts are being made to develop biomarkers that can predict individual patient responses to this compound.

FUTURE DIRECTIONS AND CONCLUSIONS

The future prospects for 6-nitro-2,3-dihydro-1H-indole hydrochloride (CAS No. 1187929-53-8) are promising. Ongoing research aims to further elucidate its mechanisms of action and explore its potential in treating a broader range of diseases. Advances in synthetic methods and drug delivery technologies will likely enhance its therapeutic utility.

In conclusion, 6-nitro-2,3-dihydro-1H-indole hydrochloride (CAS No. 1187929-53-8) represents a valuable addition to the arsenal of compounds available for chemical biology and medicinal chemistry research. Its unique structural features and diverse biological activities make it an exciting candidate for further development as a therapeutic agent.

• 32692-19-6(5-Nitroindoline)
• 18711-25-6(1H-Indole, 2,3-dihydro-1-methyl-5-nitro-)
• 115210-53-2(2,3-dihydro-1-methyl-6-nitro-1H-Indole)
• 208510-91-2(2,3-dihydro-7-methyl-4-nitro-1H-Indole)
• 30450-62-5(7-nitro-1,2,3,4-tetrahydroquinoline)
• 19727-83-4(6-Nitroindoline)
• 179898-72-7(3,3-dimethyl-6-nitro-indoline)
• 1000604-16-9(7-methyl-5-nitro-2,3-dihydro-1H-indole)
• 84807-26-1(4-Nitroindoline)
• 51134-82-8(2-Methyl-6-nitroindoline)